HOME >> MEDICINE >> NEWS
Simple breath test may replace endoscopy

A simple breath test for detecting H pylori infection is as effective and safe as endoscopy and is less uncomfortable and distressing for the patient, conclude researchers in this weeks BMJ.

The study involved 708 patients with indigestion who had been referred to hospital for endoscopic investigation (examining the stomach using a tube-like viewing instrument).

A total of 356 patients received a non-invasive breath test for H pylori and 352 received endoscopy plus H pylori testing. Patients were also asked to score the degree of discomfort or distress caused by their test, and whether they would have the same test again.

After 12 months, non-invasive testing for H pylori was as effective and as safe as endoscopy. Furthermore, it was as reassuring to the patient as endoscopy, less uncomfortable and distressing, and substantially cheaper than endoscopy.

For these reasons, non-invasive H pylori testing seems to be the preferred investigation for patients with uncomplicated dyspepsia, conclude the authors.


'"/>

Contact: Emma Wilkinson
ewilkinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
25-Apr-2002


Page: 1

Related medicine news :

1. Simple intervention encourages sun protection behaviors
2. Simple blood test may help to predict cardiovascular risk in older women
3. Simple question from your doctor can help identify your risk for breast cancer
4. Simple treatment could prevent many child malaria deaths
5. Simpler blood thinning medication effective for preventing blood clots and stroke
6. Simpler alphabet guidelines for treating acute coronary syndrome reduce risk
7. Simple sputum test for confirmation of childhood tuberculosis
8. Simple intervention nearly eliminates catheter-related bloodstream infections
9. Simple interventions for accident and emergency patients could help reduce excessive drinking
10. Simple tests could signal and prevent heart disease in women, says Pittsburgh researcher
11. Simpler, cheaper way to make and fit prosthetics developed

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Simple breath test may replace endoscopy

(Date:5/4/2015)... May 04, 2015 The opportunity for children ... life are the motivating forces behind The Fairy Godmother Next ... and author Amy L. Stark. , The inspiration for the ... next door comes from Stark’s desire to be a fairy ... a fairy godmother to my neighbors’ children since they were ...
(Date:5/4/2015)... Now in its seventh year, the ... have made outstanding contributions to the company, to their ... acute and post-acute care settings. The five award categories ... the Year, Advanced Practice Clinician of the Year, Newcomer ... Year. Recipients are selected by IPC’s senior management team. ...
(Date:5/4/2015)... 2015 Ticket Down is a reputable source ... Jones Arena in Charlottesville, VA. McCartney is one ... music business and this beloved performer continues to roll along ... member of two legendary groups: Wings and The Beatles, has ... since 2013 on the “Out There” tour and has continually ...
(Date:5/4/2015)... San Diego Fertility Center (SDFC) ... new, 13,700 square foot facility scheduled to open in ... only provide fertility treatment and services for the center’s ... educational events to a number of local and international ... to their current Carmel Valley/Del Mar location and will ...
(Date:5/4/2015)... May 04, 2015 Elisabeth Rosenthal’s ... a stir and showed the healthcare fraternity as ... healthcare procedure, the downside of balance billing. In ... healthcare provider billing a patient for the difference ... reimburse and what the provider chooses to charge. ...
Breaking Medicine News(10 mins):Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:Out of Network Balance Billing Without Being Viewed as Fraud 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 3
(Date:5/4/2015)... 2015 Bayer HealthCare (Bayer) has entered into ... ISIS ) on ISIS-FXI Rx, an antisense ... thrombosis. Under the agreement Bayer will further develop and ... medical need. As part of the clinical development program, ... Rx in an appropriate patient community. ...
(Date:5/4/2015)... BUFFALO, N.Y. , May 4, 2015 /PRNewswire/ ... Stephanie Englert , PharmD, has completed preliminary analysis ... Disorder and Schizophrenia. Resources from Clinical Support Services, ... Medication Reviews (CMR) with patients currently taking psychiatric ... events. The research found that 93% of patients ...
(Date:5/4/2015)... SAN DIEGO , May 4, 2015 /PRNewswire/ ... an oncology company focused on the clinical development ... pre-clinical data showing mitochondria-specific effects of the Company,s ... significantly enhanced anti-tumor activity when combined with a ... study found ME-344 to be a potent inhibitor ...
Breaking Medicine Technology:Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 2Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5
Cached News: